BACKGROUND: Circulating nucleic acids were discovered more than 60 y ago. With the recent developments in the study of circulating nucleic acids, its application in the diagnostic field has increased. The objective of this study was to assess the usefulness of the quantification of cell-free plasma DNA (CF-DNA) concentration in the diagnosis of infections in febrile patients and as a prognostic marker in septic patients. METHODS: Concentrations of CF-DNA, procalcitonin (PCT) and C-reactive protein (CRP) were measured in 110 febrile patients who were clinically diagnosed with fever of unknown origin, localized infection, sepsis or septic shock. RESULTS: Concentrations of CF-DNA increase according to the severity of the infection. The best cut-off point for predicting infection was 2800 GE (genome equivalents)/mL (sensitivity: 95.0%; specificity: 96.7%) and 14,000 GE/mL for sepsis prediction (sensitivity: 77.8%; specificity: 94.6%). Higher concentrations of CF-DNA were found in exitus septic patients than in survivors. The diagnostic efficiency of CF-DNA was similar to PCT and higher than CRP in infectious processes. CONCLUSIONS: Normal concentrations of CF-DNA can exclude the presence of an infection in febrile patients, and very high concentrations (>10-fold over the normal reference range) stratify the severity of infections, showing a high prognostic value to predict mortality in the absence of other causes for elevated CF-DNA.
BACKGROUND: Circulating nucleic acids were discovered more than 60 y ago. With the recent developments in the study of circulating nucleic acids, its application in the diagnostic field has increased. The objective of this study was to assess the usefulness of the quantification of cell-free plasma DNA (CF-DNA) concentration in the diagnosis of infections in febrile patients and as a prognostic marker in septic patients. METHODS: Concentrations of CF-DNA, procalcitonin (PCT) and C-reactive protein (CRP) were measured in 110 febrile patients who were clinically diagnosed with fever of unknown origin, localized infection, sepsis or septic shock. RESULTS: Concentrations of CF-DNA increase according to the severity of the infection. The best cut-off point for predicting infection was 2800 GE (genome equivalents)/mL (sensitivity: 95.0%; specificity: 96.7%) and 14,000 GE/mL for sepsis prediction (sensitivity: 77.8%; specificity: 94.6%). Higher concentrations of CF-DNA were found in exitus septicpatients than in survivors. The diagnostic efficiency of CF-DNA was similar to PCT and higher than CRP in infectious processes. CONCLUSIONS: Normal concentrations of CF-DNA can exclude the presence of an infection in febrile patients, and very high concentrations (>10-fold over the normal reference range) stratify the severity of infections, showing a high prognostic value to predict mortality in the absence of other causes for elevated CF-DNA.
Authors: Anna Neyman; Jennifer Nelson; Sarah A Tersey; Raghavendra G Mirmira; Carmella Evans-Molina; Emily K Sims Journal: Diabetes Obes Metab Date: 2018-08-24 Impact factor: 6.577
Authors: Bernardo S Franklin; Barbara L F Vitorino; Helena C Coelho; Armando Menezes-Neto; Marina L S Santos; Fernanda M F Campos; Cristiana F Brito; Cor J Fontes; Marcus V Lacerda; Luzia H Carvalho Journal: PLoS One Date: 2011-05-17 Impact factor: 3.240
Authors: Tuula K Outinen; Taru Kuparinen; Juulia Jylhävä; Sonja Leppänen; Jukka Mustonen; Satu Mäkelä; Ilkka Pörsti; Jaana Syrjänen; Antti Vaheri; Mikko Hurme Journal: PLoS One Date: 2012-02-07 Impact factor: 3.240
Authors: Ping Song; Lucia Ruojia Wu; Yan Helen Yan; Jinny X Zhang; Tianqing Chu; Lawrence N Kwong; Abhijit A Patel; David Yu Zhang Journal: Nat Biomed Eng Date: 2022-01-31 Impact factor: 29.234
Authors: Marisa M Fisher; Renecia A Watkins; Janice Blum; Carmella Evans-Molina; Naga Chalasani; Linda A DiMeglio; Kieren J Mather; Sarah A Tersey; Raghavendra G Mirmira Journal: Diabetes Date: 2015-07-27 Impact factor: 9.461